Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Risk of newly detected infections and cervical abnormalities in adult women seropositive or seronegative for naturally acquired HPV-16/18 antibodies.

Rosillon D, Baril L, Del Rosario-Raymundo MR, Wheeler CM, Skinner SR, Garland SM, Salmeron J, Lazcano-Ponce E, Vallejos CS, Stoney T, Ter Harmsel B, Lim TYK, Quek SC, Minkina G, McNeil SA, Bouchard C, Fong KL, Money D, Ilancheran A, Savicheva A, Cruickshank M, Chatterjee A, Fiander A, Martens M, Bozonnat MC, Struyf F, Dubin G, Castellsagué X.

Cancer Med. 2019 Aug;8(10):4938-4953. doi: 10.1002/cam4.1879. Epub 2019 Jul 5.

2.

Risk of HPV-16/18 Infections and Associated Cervical Abnormalities in Women Seropositive for Naturally Acquired Antibodies: Pooled Analysis Based on Control Arms of Two Large Clinical Trials.

Safaeian M, Castellsagué X, Hildesheim A, Wacholder S, Schiffman MH, Bozonnat MC, Baril L, Rosillon D; Costa Rica HPV Vaccine Trial and the PATRICIA study groups.

J Infect Dis. 2018 Jun 5;218(1):84-94. doi: 10.1093/infdis/jiy112.

3.

Induction or consolidation chemotherapy for unresectable stage III non-small-cell lung cancer patients treated with concurrent chemoradiation: a randomised phase II trial GFPC - IFCT 02-01.

Fournel P, Vergnenégre A, Robinet G, Léna H, Gervais R, Le Caer H, Souquet PJ, Chavaillon JM, Bozonnat MC, Daurès JP, Chouaid C, Martel-Lafay I; GFPC and IFCT Team.

Eur J Cancer. 2016 Jan;52:181-7. doi: 10.1016/j.ejca.2015.10.072. Epub 2015 Dec 12.

PMID:
26689864
4.

Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study.

Skinner SR, Wheeler CM, Romanowski B, Castellsagué X, Lazcano-Ponce E, Del Rosario-Raymundo MR, Vallejos C, Minkina G, Pereira Da Silva D, McNeil S, Prilepskaya V, Gogotadze I, Money D, Garland SM, Romanenko V, Harper DM, Levin MJ, Chatterjee A, Geeraerts B, Struyf F, Dubin G, Bozonnat MC, Rosillon D, Baril L; VIVIANE Study Group.

Int J Cancer. 2016 May 15;138(10):2428-38. doi: 10.1002/ijc.29971.

5.

Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial.

Castellsagué X, Paavonen J, Jaisamrarn U, Wheeler CM, Skinner SR, Lehtinen M, Naud P, Chow SN, Del Rosario-Raymundo MR, Teixeira JC, Palmroth J, de Carvalho NS, Germar MJ, Peters K, Garland SM, Szarewski A, Poppe WA, Romanowski B, Schwarz TF, Tjalma WA, Bosch FX, Bozonnat MC, Struyf F, Dubin G, Rosillon D, Baril L; HPV PATRICIA Study Group.

BMC Infect Dis. 2014 Oct 30;14:551. doi: 10.1186/s12879-014-0551-y.

6.

Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study.

Jaisamrarn U, Castellsagué X, Garland SM, Naud P, Palmroth J, Del Rosario-Raymundo MR, Wheeler CM, Salmerón J, Chow SN, Apter D, Teixeira JC, Skinner SR, Hedrick J, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, de Carvalho NS, Germar MJ, Peters K, Paavonen J, Bozonnat MC, Descamps D, Struyf F, Dubin GO, Rosillon D, Baril L; HPV PATRICIA Study Group.

PLoS One. 2013 Nov 19;8(11):e79260. doi: 10.1371/journal.pone.0079260. eCollection 2013. Erratum in: PLoS One. 2013;8(12). doi:10.1371/annotation/cea59317-929c-464a-b3f7-e095248f229a.

7.

Epirubicin and ifosfamide in relapsed or refractory small cell lung cancer patients.

Jacot W, Pujol JL, Chakra M, Molinier O, Bozonnat MC, Gervais R, Quantin X.

Lung Cancer. 2012 Feb;75(2):213-6. doi: 10.1016/j.lungcan.2011.07.012. Epub 2011 Aug 9.

PMID:
21831476
8.

[Is the use of plastic capillary tubes justified for blood gases analysis?].

Daurès MF, Bozonnat MC, Cristol JP.

Ann Biol Clin (Paris). 2011 Jan-Feb;69(1):126-30. doi: 10.1684/abc.2010.0507. French.

9.

Methotrexate pharmacokinetics in childhood acute lymphoblastic leukaemia: a prognostic value?

Martelli N, Mathieu O, Margueritte G, Bozonnat MC, Daurès JP, Bressolle F, Hillaire-Buys D, Peyrière H.

J Clin Pharm Ther. 2011 Apr;36(2):237-45. doi: 10.1111/j.1365-2710.2010.01179.x. Epub 2010 Oct 19.

PMID:
21366654
10.

Is chronic hepatitis C virus infection a risk factor for breast cancer?

Larrey D, Bozonnat MC, Kain I, Pageaux GP, Assenat E.

World J Gastroenterol. 2010 Aug 7;16(29):3687-91.

11.
12.

Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.

Aupérin A, Le Péchoux C, Rolland E, Curran WJ, Furuse K, Fournel P, Belderbos J, Clamon G, Ulutin HC, Paulus R, Yamanaka T, Bozonnat MC, Uitterhoeve A, Wang X, Stewart L, Arriagada R, Burdett S, Pignon JP.

J Clin Oncol. 2010 May 1;28(13):2181-90. doi: 10.1200/JCO.2009.26.2543. Epub 2010 Mar 29. Review.

PMID:
20351327
13.

Medico-economic evaluation of infliximab in rheumatoid arthritis--prospective French study of a cohort of 635 patients monitored for two years.

Sany J, Cohen JD, Combescure C, Bozonnat MC, Roch-Bras F, Lafon G, Daurès JP.

Rheumatology (Oxford). 2009 Oct;48(10):1236-41. doi: 10.1093/rheumatology/kep198. Epub 2009 Jul 20.

PMID:
19620209
14.

Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.

Chakra M, Pujol JL, Lamy PJ, Bozonnat MC, Quantin X, Jacot W, Daurès JP.

J Thorac Oncol. 2008 Oct;3(10):1119-26. doi: 10.1097/JTO.0b013e318187464e.

15.

Volumetric thoracic growth in children with moderate and severe scoliosis compared to subjects without spinal deformity.

Charles YP, Dimeglio A, Marcoul M, Bourgin JF, Marcoul A, Bozonnat MC.

Stud Health Technol Inform. 2008;140:22-8.

PMID:
18809993
16.

Influence of idiopathic scoliosis on three-dimensional thoracic growth.

Charles YP, Diméglio A, Marcoul M, Bourgin JF, Marcoul A, Bozonnat MC.

Spine (Phila Pa 1976). 2008 May 15;33(11):1209-18. doi: 10.1097/BRS.0b013e3181715272.

PMID:
18469694
17.

Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients.

Jacot W, Colinet B, Bertrand D, Lacombe S, Bozonnat MC, Daurès JP, Pujol JL; OncoLR health network.

Ann Oncol. 2008 Aug;19(8):1458-64. doi: 10.1093/annonc/mdn064. Epub 2008 Mar 19.

19.

A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index.

Colinet B, Jacot W, Bertrand D, Lacombe S, Bozonnat MC, Daurès JP, Pujol JL; oncoLR health network.

Br J Cancer. 2005 Nov 14;93(10):1098-105.

20.

Optimizing the use of anti-interleukin-6 monoclonal antibody with dexamethasone and 140 mg/m2 of melphalan in multiple myeloma: results of a pilot study including biological aspects.

Rossi JF, Fegueux N, Lu ZY, Legouffe E, Exbrayat C, Bozonnat MC, Navarro R, Lopez E, Quittet P, Daures JP, Rouillé V, Kanouni T, Widjenes J, Klein B.

Bone Marrow Transplant. 2005 Nov;36(9):771-9.

21.

Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study.

Fournel P, Robinet G, Thomas P, Souquet PJ, Léna H, Vergnenégre A, Delhoume JY, Le Treut J, Silvani JA, Dansin E, Bozonnat MC, Daurés JP, Mornex F, Pérol M; Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie.

J Clin Oncol. 2005 Sep 1;23(25):5910-7. Epub 2005 Aug 8.

PMID:
16087956
22.

Influence of sex on disease severity in patients with rheumatoid arthritis.

Gossec L, Baro-Riba J, Bozonnat MC, Daurès JP, Sany J, Eliaou JF, Combe B.

J Rheumatol. 2005 Aug;32(8):1448-51.

PMID:
16078318
23.

[Validation of an asthma knowledge questionnaire].

Nguyen L, Raherison C, Bozonnat MC, Lheureux M, Nocent C, Tunon-de-Lara JM, Taytard A.

Rev Mal Respir. 2003 Dec;20(6 Pt 1):871-80. French.

PMID:
14743088
24.

Secondary addition of methotrexate to partial responders to etanercept alone is effective in severe rheumatoid arthritis.

Cohen JD, Zaltni S, Kaiser MJ, Bozonnat MC, Jorgensen C, Daurès JP, Sany J.

Ann Rheum Dis. 2004 Feb;63(2):209-10. No abstract available.

25.

Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis.

Combe B, Cantagrel A, Goupille P, Bozonnat MC, Sibilia J, Eliaou JF, Meyer O, Sany J, Dubois A, Daurès JP, Dougados M.

J Rheumatol. 2003 Nov;30(11):2344-9.

PMID:
14677175
26.

Variable virological outcomes according to the center providing antiretroviral therapy within the PharmAdapt clinical trial.

Clevenbergh P, Bozonnat MC, Kirstetter M, Durant J, Cua E, del Giudice P, Montagne N, Simonet P; Group InfectioSud.

HIV Clin Trials. 2003 Mar-Apr;4(2):84-91.

PMID:
12671775
27.

Financial costs of alcoholism treatment programs: a longitudinal and comparative evaluation among four specialized centers.

Nalpas B, Combescure C, Pierre B, Ledent T, Gillet C, Playoust D, Danel T, Bozonnat MC, Martin S, Balmès JL, Daurès JP.

Alcohol Clin Exp Res. 2003 Jan;27(1):51-6.

PMID:
12544005
28.

Effect of etanercept on tenosynovitis and nodules in rheumatoid arthritis.

Kaiser M-, Bozonnat M-, Jorgensen C, Daurès J-, Sany J.

Arthritis Rheum. 2002 Feb;46(2):559-60. No abstract available.

29.

Preliminary evaluation of medical outcomes (including quality of life) and costs in incident RA cases receiving hospital-based multidisciplinary management.

Maravic M, Bozonnat MC, Sevezan A, Gasqueres D, Pastor J, Péré M, Neil V, Roch-Bras F, Daures JP, Sany J.

Joint Bone Spine. 2000;67(5):425-33.

PMID:
11143909

Supplemental Content

Loading ...
Support Center